The new fiscal year is already two days into its own ledger. On 2 October 2026, FDA issued a letter to Hanlim Pharm in Yongin ...
The company said the three data sets together give a clearer picture of the product it actually sells than any single ...
Parkinson’s patients elevated baseline inflammation demonstrated statistically significant improvements in both motor and non ...
J&J's icotrokinra hit every UC endpoint in NEJM's Oct 2026 data, and the trial design choices behind that success are ...
The FDA has released final guidance detailing the information required to demonstrate the identity and safety of new dietary ...
Haemonetics stock edges higher on the day, trading at $118.73 while the PerQseal Elite system receives FDA approval.
The AHA provided recommendations to the Food and Drug Administration Oct. 19 on potential regulatory frameworks for ...
Washington is loosening oversight of clinical AI while California and other states are writing their own rules. A physician ...
Federal recall records identify the USVI as a distribution area for ICU Medical IV tubing sets after reports of black specks ...
BioVie Inc. (NASDAQ: BIVI) (“BioVie” or the “Company”), a clinical-stage company developing innovative drug therapies for neurological and neurodegenerative diseases, today announced the presentation ...
Frontiers in Pharmacology has retracted a 2020 study on the oleander-derived drug PBI-05204 for glioblastoma after image ...
Sonu’s Diabetes Secret has published its first formal content integrity and transparency report, combining findings from a 60-day customer outcomes survey of verified purchasers, a sweep of the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results